Leading generics pharmaceutical company
Current Events
Medicare could have saved nearly 90% of spending on angiotensin converting enzyme inhibitors and angiotensin-II-receptor blockers in 2016 and 2017 through generic substitute or therapeutic interchange, according to study results published in JAMA Internal Medicine. “Prescription drug spending accounts for an increasing share of U.S. health care costs.” Mathew E. Growdon, MD, MPH, of the […]
As per the study conducted by Journal of Drug Delivery and Therapeutics, about 62% of healthcare providers want to substitute generic drugs but not for all the cases they treat, thus indicates the perception of the efficacy of the two classes of medicines. With the escalating cost of healthcare facilities, many people in India […]
It’s pretty much just two women who name the 200-plus drugs that come out every year Generic prescriptions allow patients to get the medicines they need at a lower price, without sacrificing the quality of treatment because, as we know, generic drugs are required by the FDA to be nearly identical to their name-brand […]
Effective 1 July 2019, the EU adopted a regulation by introducing a supplementary protection certificate (SPC) manufacturing and stockpiling waiver. This waiver also applies for biosimilar versions of SPC-protected medicine during the term of the SPC. SPC’s are defined as IP rights extending patent protection for up to five years for medicines that are […]
A nationwide shortage of a generic drug that can shrink and control brain tumors in children raises questions about how critical medicines can go scarce. Life-saving pediatric cancer drugs are frequently unavailable due to shortages. Since being diagnosed with a brain tumor nearly a year ago, my son has lived much like any 5-year-old – in […]
Here’s what to look out for — other than the packaging Prescription drug costs are an issue for millions of Americans, many of whom use prescription medicine on a daily basis. And since Medicare doesn’t always cover brand-name drugs, it’s worth giving some thought to what exactly, if any, are the differences between brand name and […]
Latest Mediscor review says generic utilisation rate more than doubled from 27.7% in 2002 to 62.4% in 2018 The use of cheaper generic alternatives that are no longer patent-protected rose to an all-time high in the private sector in 2018, according to the latest Mediscor review. The trend highlights the continued impact of the […]
This morning, Health Canada announced the final amendments to the Patented Medicines Regulations (see news release here and RIAS here). These amendments represent the first substantive revision to the Regulations since their introduction in 1987, and a significant departure from the existing framework. The amended Regulations will come into force on July 1, 2020 […]
Vaghela was speaking at the inaugural edition of the ‘CME Summit and Excellence Awards’ organized by the Indian Health and Wellness Council (IHW). Controlling medicine prices through Drug Price Control Order (DPCO) 2017 saved at least Rs 12,400 crores, pharma secretary PD Vaghela said on Thursday. Jan Aushadhi stores are also growing steadily in the […]
There is a question about what role race and wealth play in how much attention and funding the disease receives. Sickle cell disease affects about 100,000 Americans, most of them African-Americans. There are few treatments for it, and experts say not enough is being done to prevent complications. Just recently, the Centers for Medicare […]
